-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Csaba P. Kovesdy, MD

Articles by Csaba P. Kovesdy, MD

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Targeted Literature Review of the Burden of Illness in Patients With Chronic Kidney Disease and Type 2 Diabetes

ByLinda F. Fried, MD, MPH,Kerstin Folkerts, MSc,Beata Smela, MSc,Kevin Deon Bowrin, MSc,Paul Mernagh, MCom,Aurelie Millier, PhD,Csaba P. Kovesdy, MD

May 11th 2021

Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes

ByEleanor O. Caplan, PhD,Richard Sheer, BA,Niklas Schmedt, DrPH,Thomas Evers, PhD,Meghan Cockrell, MPH,Michael Tindal, PharmD, MBA,Margaret K. Pasquale, PhD,Csaba P. Kovesdy, MD

May 11th 2021

Latest Updated Articles

Targeted Literature Review of the Burden of Illness in Patients With Chronic Kidney Disease and Type 2 Diabetes
May 11th 2021
Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes
May 11th 2021
ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021

Trending on AJMC

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

$20 Billion National Strategy Aims to Close the Women's Health Gap

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care